Tomas Hernandez
Pediatrics, Critical Care · Wichita, KSNPI 1285978544
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations.
Across 258 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- UCB, Inc.$1K
- AbbVie$605
- Neurelis, Inc.$455
- SK Life Science, Inc.$247
- Eisai Inc.$198
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,10995%
- Education$2545%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 50 | $1,282 |
| UCB, Inc. | 71 | $1,179 |
| AbbVie | 29 | $605 |
| Neurelis, Inc. | 22 | $455 |
| SK Life Science, Inc. | 11 | $247 |
| Eisai Inc. | 12 | $198 |
| Supernus Pharmaceuticals, Inc. | 4 | $160 |
| Sumitomo Pharma America, Inc. | 11 | $148 |
| Acadia Pharmaceuticals Inc | 7 | $146 |
| Immedica Pharma US, Inc. | 6 | $143 |
| Biogen | 3 | $138 |
| Argenx US, Inc. | 5 | $111 |
| Catalyst Pharmaceuticals, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Ipsen Biopharmaceuticals, Inc | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 3 | $54 |
| Cranial Technologies, Inc | 3 | $49 |
| AstraZeneca | 2 | $44 |
| Sarepta Therapeutics, Inc. | 2 | $43 |
| Philips North America LLC | 2 | $41 |
| Genentech USA, Inc. | 1 | $25 |
| NS Pharma, Inc. | 1 | $22 |
| Zogenix Inc. | 1 | $21 |
| Pyros Pharmaceuticals, Inc. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatrics, critical care providers in Kansasto place this figure against a meaningful peer group, so we don't.
Other pediatrics, critical care in Wichita
- Laura MartisOlathe$48
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.